Stocks and Investing
Stocks and Investing
Wed, January 24, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, January 23, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mark Purcell Initiated (AZN) at Buy and Held Target at $85 on, Jan 23rd, 2024
Mark Purcell of Morgan Stanley, Initiated "AstraZeneca PLC" (AZN) at Buy and Held Target at $85 on, Jan 23rd, 2024.
Mark has made no other calls on AZN in the last 4 months.
There is 1 other peer that has a rating on AZN. Out of the 1 peers that are also analyzing AZN, all agrees with Mark's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Peter Welford of "Jefferies" Downgraded from Strong Buy to Hold on, Wednesday, January 3rd, 2024
Contributing Sources